Investment Management Corporation’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-367
Closed -$44.4K 126
2025
Q2
$44.4K Buy
367
+54
+17% +$6.09K 0.04% 86
2025
Q1
$34.9K Buy
313
+198
+172% +$21.1K 0.03% 93
2024
Q4
$11.2K Buy
+115
New +$12.3K 0.01% 137

Other funds holding NVS

Investment Management Corporation's NVS Position: Q3 2025 in Review

Investment Management Corporation sold out of Novartis (NVS) in Q3 2025, closing a stake of 367 shares — an estimated $44.4K sold.

Investment Management Corporation first reported a position in NVS in Q4 2024 and held it in 3 quarters. The position peaked at $44.4K in Q2 2025. 1,401 funds tracked by Wall St. Rank hold NVS as of Q3 2025.

  • Investment Management Corporation reported no remaining Novartis position as of Q3 2025 after selling out during the quarter.
  • Investment Management Corporation sold 367 Novartis shares in Q3 2025, an estimated $44.4K.
  • Investment Management Corporation first reported a position in Novartis in Q4 2024 and held it in 3 quarters.
  • Investment Management Corporation's Novartis position peaked at $44.4K in Q2 2025.
  • 1,401 funds tracked by Wall St. Rank held Novartis as of Q3 2025.

Based on Investment Management Corporation's 13F filing for Q3 2025, filed 30 Oct 2025.